Individuals Coming Off Slimming Medications Gain Back Pounds Four Times Faster Compared to Dieters

Fresh analysis reveals that individuals who stop using new weight-loss injections like Mounjaro or Wegovy may regain reduced body mass far faster than those who end conventional diet and exercise programs.

Research printed in a prominent health publication points out that while overweight individuals can lose a large proportion of their body weight while undergoing treatment, the mass returns at an average rate of 0.8 kg per month upon discontinuation.

"Users buying these drugs must be aware of the risk of quick weight regain when the treatment concludes," stated researcher Dr. Susan Jebb.

Such speed of recovery means a return to starting weight in about a year and a half.

Analyzing Treatments

The analysis, which reviewed dozens of trials involving thousands of participants, compared the outcomes of these new drugs with older methods.

Scientists note that individuals who shed pounds through diet and exercise usually experience a slower creep back—approximately 100 grams monthly—post-intervention.

Understanding the Quick Regain

Nutrition scientists suggest the mechanism of the injections explains the heightened rebound.

These medications mimic a natural hormone called GLP-1, which moderates feelings of fullness.

"Artificially providing the hormone levels far above than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this hormone supplement results in hunger is uncontrolled, making overeating much more probable."

A Lifelong Disease?

Health authorities recommend the injections for people with obesity-related health risks, alongside recommended diet and exercise modifications.

Many experts argue that, considering the likelihood of weight regain, the therapy is often long-term.

This view is supported by pharmaceutical companies, who state that the results "underscore the persistent nature of excess weight," akin to managing diseases like high blood pressure.

User Experiences

Users who have discontinued the jabs report a powerful resurgence of cravings.

"I experienced a trigger flipping and you're instantly ravenous," said a patient.

This challenge is exacerbated if individuals have not adopted lasting dietary or behavioural modifications during therapy.

Significant Use

Survey data indicate that millions of people in the UK have tried weight-loss jabs in the past year, with demand remaining high.

• Use is more common among females than males.
• The middle-aged demographic shows the highest usage rates.
• Many obtain the medications through private prescriptions rather than public health services.

Finally, experts stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent fix and long-term success hinges on integrated behavioural management.